Evidence map›Paper›PMID 31200723›Full record

ArticleLipids in health and disease2019

Association of Omentin rs2274907 and FTO rs9939609 gene polymorphisms with insulin resistance in Iranian individuals with newly diagnosed type 2 diabetes.

Amirhosein Khoshi, Mehdi Kaffash Bajestani, Habibesadat Shakeri, Golnaz Goodarzi, Fatemeh Azizi

Abstract read
In one paragraph

Article in Lipids in health and disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Association of fat mass and obesity-associated (Journal of diabetes and metabolic disorders · 2022
    Review
  11. Review
  12. Review
  13. Review
  14. N6-Adenosine Methylation (mJournal of cardiovascular translational research · 2021
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Amirhosein KhoshiDepartment of Clinical Biochemistry, School of Medicine, North Khorasan University of Medical Sciences, Arkan roadway, Bojnurd, IR, Iran. ahkh83@gmail.com.ORCID http://orcid.org/0000-0001-9520-1857
Mehdi Kaffash BajestaniEducational Development Center, North Khorasan University of Medical Sciences, Bojnurd, IR, Iran.
Habibesadat ShakeriClinical Endocrinology, Department of Endocrinology and Internal Medicine, Imam Hassan Hospital, North Khorasan University of Medical Sciences, Bojnurd, Iran. drhssh@yahoo.com.
Golnaz GoodarziDepartment of Clinical Biochemistry, School of Medicine, North Khorasan University of Medical Sciences, Arkan roadway, Bojnurd, IR, Iran.
Fatemeh AziziStudent Research Committee, North Khorasan University of Medical Sciences, Bojnurd, IR, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInsulin resistance (IR) and fat accumulation in visceral adipose tissue are key players in developing type 2 diabetes (T2D). Several adipose tissue derived-gene polymorphisms are related to higher body mass index (BMI), insulin resistance and T2D. The association of omentin rs2274907 (Val109Asp) and fat-mass and obesity-associated (FTO) rs9939609 gene polymorphisms with overweight/obesity and T2D is controversial. The aim of this study was to determine the association between omentin Val109Asp and FTO rs9939609 polymorphisms and insulin resistance in newly-diagnosed T2D patients.

methodsThe case-control study included 83 newly-diagnosed T2D patients and 85 healthy matched controls, aged 20-80 years. Fasting blood glucose and insulin levels were measured by the enzymatic method and enzyme-linked-immunosorbent assay, respectively. Insulin resistance was calculated using the homeostasis model assessment (HOMA) index. Genotyping was examined using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).

resultsThere are significant differences between both omentin Val109Asp and FTO rs9939609 polymorphisms and studied individuals (P = 0.011 and P = 0.0001, respectively). Both genetic polymorphisms of omentin Val109Asp and FTO rs9939609 (T/A) are significantly related to higher HOMA index (P = 0.030 and P = 0.046, respectively). However, omentin Val109Asp polymorphism was only related to individuals who were overweight/obese. Additionally, both omentin Val109Asp and FTO rs9939609 polymorphisms were significantly positively correlated to familial history of diabetes (P = 0.046 and P = 0.024, respectively).

conclusionsOmentin V109D and FTO rs9939609 genetic variations may change insulin metabolism and have key roles in developing T2D through insulin resistance. Thus, the evaluation of these polymorphic regions may be helpful for predicting type 2 diabetes.

Indexed as

AdultAgedAged, 80 and overAlpha-Ketoglutarate-Dependent Dioxygenase FTOBlood GlucoseBody Mass IndexCase-Control StudiesCytokinesDiabetes Mellitus, Type 2Genetic Predisposition to DiseaseGPI-Linked ProteinsHumansInsulin ResistanceIranLectinsMiddle AgedAlpha-Ketoglutarate-Dependent Dioxygenase FTOBlood GlucoseCytokinesFTO protein, humanGPI-Linked ProteinsITLN1 protein, humanLectinsFat mass-and obesity associated (FTO)Gene polymorphismInsulin resistanceOmentinType 2 diabetes

Identifiers

PMID31200723
PMCPMC6570836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.